专利号:US-2014315720-A1 优先权日:2012-10-24 标 题 :Polysaccharide ester microspheres and methods and articles relating thereto 发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY 权利人:CELANESE ACETATE LLC 摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.
1: Davani F, Alishahi M, Sabzi M, Khorram M, Arastehfar A, Zomorodian K. Dual drug delivery of vancomycin and imipenem/cilastatin by coaxial nanofibers for treatment of diabetic foot ulcer infections. Mater Sci Eng C Mater Biol Appl. 2021 Apr;123:111975. doi: 10.1016/j.msec.2021.111975. Epub 2021 Feb 15. 81(3):377-388. doi: 10.1007/s40265-021-01471-8. Epub 2021 Feb 25. 3: Yamada K, Jahangiri Y, Li J, Gabr A, Anoushiravani A, Kumagai K, Uchida B, Farsad K, Horikawa M. Embolic Characteristics of Imipenem-Cilastatin Particles in Vitro and in Vivo: Implications for Transarterial Embolization in Joint Arthropathies. J Vasc Interv Radiol. 2021 Feb 16:S1051-0443(21)00336-5. doi: 10.1016/j.jvir.2021.02.006. Epub ahead of print. 78(8):674-683. doi: 10.1093/ajhp/zxab012. 65(4):e02141-20. doi: 10.1128/AAC.02141-20. 22(3):1239. doi: 10.3390/ijms22031239.